or Try an Advanced Search...

    Technical Analysis for GRI - GRI Bio, Inc.

    Grade Last Price % Change Price Change
    F 0.30 -8.73% -0.03
    GRI closed down 8.73 percent on Friday, May 31, 2024, on 64 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: Jun 7
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical GRI trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    Spinning Top Other 0.00%
    Calm After Storm Range Contraction 0.00%
    NR7 Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Below Lower BB Weakness 0.00%
    Gapped Down Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Older End-of-Day Signals for GRI ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 1 day ago
    Down 10% 2 days ago
    60 Minute Opening Range Breakdown 2 days ago
    Fell Below Previous Day's Low 2 days ago
    Lower Bollinger Band Support 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    GRI Chart by TradingView
    Basic chart:

    Profile

    GRI Bio, Inc., a development stage biotech company, develops Natural Killer T (NKT) cell-based therapies for liver disease and autoimmunity. Its program includes GRI-0621, an inhibitor of type 1 NKT cells that is developed as an oral therapeutic for liver disease. GRI Bio, Inc. was formerly know as Glycoregimmune, Inc. GRI Bio, Inc. was incorporated in 2009 and is based in LA Jolla, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Immunology Immune System Autoimmunity Liver Disease Natural Killer Cell Lymphocytes T Cell Natural Killer T Cell

    Is GRI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 22 GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment Highlighting Positive Preclinical Data from Idiopathic Pulmonary Fibrosis (IPF) and Systemic Lupus Erythematosus (SLE) Programs
    May 21 GRI Bio Presents Positive Preclinical Data from Pipeline of NKT Cell Modulators in Development for the Treatment of Systemic Lupus Erythematosus (SLE)
    May 20 GRI Bio Presents Positive Preclinical Data Demonstrating Lead Program GRI-0621 Reduces the Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)
    May 14 GRI Bio to Present at Alliance Global Partner’s 2024 Healthcare Company Showcase
    May 13 GRI Bio reports Q1 results
    May 13 GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
    May 10 GRI Bio files for $75M mixed shelf
    Apr 29 GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on Autoimmunity
    Apr 25 GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
    Apr 16 GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea Patent
    See more GRI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 47.95
    52 Week Low 0.2882
    Average Volume 280,944
    200-Day Moving Average 4.45
    50-Day Moving Average 0.49
    20-Day Moving Average 0.39
    10-Day Moving Average 0.37
    Average True Range 0.05
    RSI (14) 27.54
    ADX 20.62
    +DI 10.89
    -DI 23.70
    Chandelier Exit (Long, 3 ATRs) 0.34
    Chandelier Exit (Short, 3 ATRs) 0.43
    Upper Bollinger Bands 0.48
    Lower Bollinger Band 0.30
    Percent B (%b) -0.01
    BandWidth 44.30
    MACD Line -0.05
    MACD Signal Line -0.05
    MACD Histogram -0.0022
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.34
    Resistance 3 (R3) 0.34 0.33 0.33
    Resistance 2 (R2) 0.33 0.32 0.33 0.33
    Resistance 1 (R1) 0.32 0.31 0.31 0.31 0.33
    Pivot Point 0.30 0.30 0.30 0.30 0.30
    Support 1 (S1) 0.29 0.29 0.29 0.29 0.27
    Support 2 (S2) 0.28 0.29 0.28 0.27
    Support 3 (S3) 0.27 0.28 0.27
    Support 4 (S4) 0.26